Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis

Bibliographic Details
Main Authors:	Brounais-Le Royer, B, Pierroz, D, Ebetino, H, Russell, G, Ferrari, S
Format:	Conference item
Published:	2012

Similar Items

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
by: Mabilleau, G, et al.
Published: (2011)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
by: Roelofs, A, et al.
Published: (2005)

Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
by: Sugiyama, T, et al.
Published: (2011)

NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro
by: Roelofs, A, et al.
Published: (2004)

Risedronate-loaded aerogel scaffolds for bone regeneration
by: Nahla El-Wakil, et al.
Published: (2023-12-01)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
by: Kashemirov, B, et al.
Published: (2008)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
by: Kavanagh, K, et al.
Published: (2006)

Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain
by: Enrique Casado, et al.
Published: (2023-09-01)

The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007-04-01)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
by: Marma, MS, et al.
Published: (2007)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
by: Coxon, F, et al.
Published: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
by: Coxon, F, et al.
Published: (2008)

Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.
by: Roelofs, A, et al.
Published: (2006)

Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget’s Disease of Bone with <i>PFN1</i> Mutation Are Treatable by Alendronate
by: Zhu Ling, et al.
Published: (2023-10-01)

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
by: Seeman, E, et al.
Published: (2010)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin
by: Dragos Apostu, et al.
Published: (2022-08-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)

S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis
by: Jinhua Zhang, et al.
Published: (2018-08-01)

Risedronate, and its phosphonocarboxylate analogue NE10790, both induce apoptosis, but have differential effects on the cell cycle and protein prenylation in human myeloma cells.
by: Roelofs, A, et al.
Published: (2004)

Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis
by: Madeline R. Barron, et al.
Published: (2022-08-01)

Substitution of the R1 hydroxyl and C1 phosphate of risedronate produces differences in elution profiles on hydroxyapatite ceramic chromatographic columns
by: Xia, Z, et al.
Published: (2006)

Substitutions in the R1 hydroxyl and C1 phosphate positions significantly affect binding of risedronate during hydroxyapatite ceramic chromatography
by: Xia, Z, et al.
Published: (2006)

Effects of Alendronate and Raloxifene on Bone Density and Bone Turnover Markers in Postmenopausal Women
by: Ebru Zülfikaroğlu, et al.
Published: (2011-04-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2015-10-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2012-10-01)

Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis
by: Lyudmila Belenska-Todorova, et al.
Published: (2021-08-01)

Effects of odanacatib on bone matrix mineralization in rhesus monkeys are similar to those of alendronate
by: Barbara M. Misof, et al.
Published: (2016-12-01)

Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon
by: Sheng Song, et al.
Published: (2023-02-01)

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
by: Watts, N, et al.
Published: (2004)

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
by: Amy L. Inselman, et al.
Published: (2024-04-01)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
by: Duncan, E, et al.
Published: (2005)

GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis
by: Sanderlin, Edward J., et al.
Published: (2018)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
by: Ma. Florencia Peralta, et al.
Published: (2021-05-01)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
by: Sarah Morice, et al.
Published: (2020-03-01)

Effect of Nano-Capsules Containing Risedronate on Calvarial Bone Formation in Rabbit: Radiography and Biochemical Investigation
by: Hesam Aldin Hoseinzadeh, et al.
Published: (2018-01-01)

Colon-Targeted eNAMPT-Specific Peptide Systems for Treatment of DSS-Induced Acute and Chronic Colitis in Mouse
by: Jae-Sung Kim, et al.
Published: (2022-11-01)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
by: Diane Kleinermans, et al.
Published: (2022-06-01)

Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trial
by: Darrell H. S. Tan, et al.
Published: (2019-11-01)